Biomarkers · Chemical
Non-HDL Cholesterol
- Primary unit
- mg/dL
- LOINC codes
- 43396-1
- Tests that measure Non-HDL Cholesterol
- Labcorp 14, Quest Diagnostics 8
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, ASCVD Risk Panel with Score 92053
| Total Cholesterol | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
| <20 Years | <170 | <170 |
| ≥20 Years | <200 | <200 |
| HDL Cholesterol | ||
| <20 Years | >45 | >45 |
| ≥20 Years | ≥40 | ≥50 |
| Triglycerides | ||
| ≤9 Years | <75 | <75 |
| 10-19 Years | <90 | <90 |
| ≥20 Years | <150 | <150 |
| LDL-Cholesterol (Calc) | ||
| <20 Years | <110 | <110 |
| ≥20 Years | <100 | <100 |
| Cholesterol/HDL Ratio (Calc) | <5.0 | <5.0 |
| Non-HDL Cholesterol | ||
| <20 Years | <120 | <120 |
| ≥20 Years | <130 | <130 |
| ASCVD Risk Scores | See Laboratory Report |
Quest Diagnostics, Lipid Panel with Ratios 19543
| Total Cholesterol | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
| <20 Years | <170 | <170 |
| ≥20 Years | <200 | <200 |
| HDL Cholesterol | ||
| <20 Years | >45 | >45 |
| ≥20 Years | ≥40 | ≥50 |
| Triglycerides | ||
| ≤9 Years | <75 | <75 |
| 10-19 Years | <90 | <90 |
| ≥20 Years | <150 | <150 |
| LDL-Cholesterol (Calc) | ||
| <20 Years | <110 | <110 |
| ≥20 Years | <100 | <100 |
| Cholesterol/HDL Ratio (Calc) | <5.0 | <5.0 |
| LDL/HDL Ratio (Calc) | ||
| Below Average Risk | <2.28 | <2.34 |
| Average Risk | 2.29-4.90 | 2.35-4.12 |
| Moderate Risk | 4.91-7.12 | 4.13-5.56 |
| High Risk | >7.13 | >5.57 |
| Non-HDL Cholesterol | ||
| <20 Years | <120 | <120 |
| ≥20 Years | <130 | <130 |
Quest Diagnostics, Lipid Panel with Reflex to Direct LDL 14852
| Total Cholesterol | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
| <20 Years | <170 | <170 |
| ≥20 Years | <200 | <200 |
| HDL Cholesterol | ||
| <20 Years | >45 | >45 |
| ≥20 Years | ≥40 | ≥50 |
| Triglycerides | ||
| ≤9 Years | <75 | <75 |
| 10-19 Years | <90 | <90 |
| ≥20 Years | <150 | <150 |
| LDL-Cholesterol (Calc) | ||
| <20 Years | <110 | <110 |
| ≥20 Years | <100 | <100 |
| Cholesterol/HDL Ratio (Calc) | <5.0 | <5.0 |
| Non-HDL Cholesterol | ||
| <20 Years | <120 | <120 |
| ≥20 Years | <130 | <130 |
Quest Diagnostics, Lipid Panel, Non-Fasting without Triglycerides 91247
| Total Cholesterol | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
| <20 Years | <170 | <170 |
| ≥20 Years | <200 | <200 |
| HDL Cholesterol | ||
| <20 Years | >45 | >45 |
| ≥20 Years | ≥40 | ≥50 |
| Cholesterol/HDL Ratio (calc) | <5.0 | <5.0 |
| Non-HDL Cholesterol (calc) | ||
| <20 Years | <120 | <120 |
| ≥20 Years | <130 | <130 |
Quest Diagnostics, Lipid Panel, Standard 7600
| Total Cholesterol | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
| <20 Years | <170 | <170 |
| ≥20 Years | <200 | <200 |
| HDL Cholesterol | ||
| <20 Years | >45 | >45 |
| ≥20 Years | ≥40 | ≥50 |
| Triglycerides | ||
| ≤9 Years | <75 | <75 |
| 10-19 Years | <90 | <90 |
| ≥20 Years | <150 | <150 |
| LDL-Cholesterol (calc) | ||
| <20 Years | <110 | <110 |
| ≥20 Years | <100 | <100 |
| Cholesterol/HDL Ratio (calc) | <5.0 | <5.0 |
| Non-HDL Cholesterol (calc) | ||
| <20 Years | <120 | <120 |
| ≥20 Years | <130 | <130 |
Tests
Check the catalog code, specimen, method and preparation for every test that measures Non-HDL Cholesterol. Select up to five tests to compare them side by side.
Labcorp 14 tests
Panels that include this biomarker
Lipid Profile, Nonfasting, Pediatric 373634
3 analytes · Serum · No fasting · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Enzymatic
- Preparation
- Nonfasting
- Collection
- Separate serum or plasma or from cells within 45 minutes of collection.
Non-HDL Cholesterol Profile 344265
3 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- See individual tests.
- Preparation
- Patient should be on a stable diet, ideally for two to three weeks prior to collection of the specimen.
- Collection
- Separate serum from cells within 45 minutes of venipuncture. Lipid profiles are best avoided following acute myocardial infarct, for up to three months, although cholesterol can be measured in the first 24 hours.
Lipid Profile, Fasting, Pediatric 373632
5 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Enzymatic
- Preparation
- Patient should be on stable diet, ideally for two to three weeks prior to collection of blood, and should fast for 12 to 14 hours before collection of the specimen.
- Collection
- Separate serum or plasma or from cells within 45 minutes of collection.
Lipid Cascade With Reflex to Apolipoprotein B 363676
6 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Enzymatic
- Preparation
- Patient should be fasting for eight hours.
- Collection
- Separate serum or plasma from cells within 45 minutes of collection.
Lipid Cascade With Reflex to Lipoprotein Particle Assessment by NMR (With Graph if Reflexed) 123836
6 analytes · Serum · Fasting not stated · Turnaround Within 1 day
Labcorp catalog pageMethod and collection
- Method
- Lipid profile: Enzymatic Lipoprotein reflex: Nuclear magnetic resonance (NMR)
- Preparation
- Patient should be fasting for a minimum of eight to 12 hours.
- Collection
- Lipid profile: Separate serum or plasma from cells within 45 minutes of collection. Lipoprotein reflex: Collect specimen in NMR LipoTube (black-and-yellow-top gel-barrier tube), which is the preferred tube. Keep upright at room temperature for 30 minutes and allow to clot. Immediately after clotting, centrifuge at 1600 to 1800 xg for 10 to 15 minutes. The NMR LipoTube should then be stored at 2°C to 8°C until shipped. Do not open NMR LipoTube. For plain serum (red-top, no gel), keep upright at room temperature for 45 minutes and allow to clot. Centrifuge immediately after clotting. Separate serum and transfer to a plastic transport tube. The serum should then be stored at 2°C to 8°C until shipped. For EDTA plasma (lavender-top, no gel), invert tube several times to mix contents and centrifuge immediately after collection. Separate plasma and transfer to a plastic transport tube. The plasma should then be stored at 2°C to 8°C until shipped. Serum or plasma drawn in gel-barrier collection tubes other than the NMR LipoTube should not be used.
Quest Diagnostics 8 tests
Panels that include this biomarker
Lipid Panel, Non-Fasting without Triglycerides 91247
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP)
- Preparation
- If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
Lipid Panel with Reflex to Direct LDL 14852
6 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP)
- Preparation
- If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
- Collection
- Centrifuge within 30-60 minutes following collection
Lipid Panel, Standard 7600
6 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP)
- Preparation
- If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
ASCVD Risk Panel with Score 92053
7 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Enzymatic • Spectrophotometry (SP)
- Preparation
- If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
- Collection
- For risk calculations to be performed, the following patient specific information have to be provided at time of order: Age: Years Gender: M (for male) or F (for female) Race-African American: Y (for yes) or N (for no) Systolic Blood Pressure: mmHg Treatment for High Blood Pressure: Y (for yes) or N (for no) Diabetes Status: Y (for yes) or N (for no) Smoking Status: Y (for Yes) or N (for no)
Lipid Panel with Ratios 19543
7 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Spectrophotometry (SP)
- Preparation
- If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
- Collection
- Centrifuge within 30-60 minutes following collection
0 of 5 tests selected
Pick one moreSources
14 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
8 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 43396-1
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Non-HDL Cholesterol
Registered studies that measure Non-HDL Cholesterol, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.